BAGELLA, Luigi Marco
 Distribuzione geografica
Continente #
NA - Nord America 3.756
AS - Asia 2.106
SA - Sud America 1.385
EU - Europa 1.227
AF - Africa 86
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 8
Totale 8.577
Nazione #
US - Stati Uniti d'America 3.658
BR - Brasile 1.218
SG - Singapore 911
CN - Cina 614
UA - Ucraina 416
DE - Germania 213
HK - Hong Kong 170
IT - Italia 132
SE - Svezia 125
VN - Vietnam 94
FI - Finlandia 86
GB - Regno Unito 76
AR - Argentina 61
CA - Canada 43
IN - India 43
TR - Turchia 39
IQ - Iraq 36
RU - Federazione Russa 35
MX - Messico 32
JP - Giappone 29
EC - Ecuador 27
BD - Bangladesh 25
PL - Polonia 25
ZA - Sudafrica 23
MA - Marocco 22
VE - Venezuela 22
UZ - Uzbekistan 21
ES - Italia 20
BE - Belgio 16
KR - Corea 16
FR - Francia 15
PK - Pakistan 15
CO - Colombia 14
PY - Paraguay 12
AT - Austria 11
IR - Iran 11
JO - Giordania 11
CZ - Repubblica Ceca 10
KE - Kenya 9
LT - Lituania 9
NL - Olanda 9
PE - Perù 9
AU - Australia 8
CL - Cile 8
RO - Romania 7
SA - Arabia Saudita 7
TN - Tunisia 7
UY - Uruguay 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
EG - Egitto 6
EU - Europa 6
NP - Nepal 6
GE - Georgia 5
JM - Giamaica 5
KH - Cambogia 5
AL - Albania 4
AZ - Azerbaigian 4
CI - Costa d'Avorio 4
DZ - Algeria 4
IL - Israele 4
KG - Kirghizistan 4
PA - Panama 4
BN - Brunei Darussalam 3
DO - Repubblica Dominicana 3
ID - Indonesia 3
IE - Irlanda 3
KZ - Kazakistan 3
LB - Libano 3
OM - Oman 3
RS - Serbia 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
GT - Guatemala 2
HU - Ungheria 2
LK - Sri Lanka 2
ML - Mali 2
MU - Mauritius 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BB - Barbados 1
BG - Bulgaria 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
GA - Gabon 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
KW - Kuwait 1
LI - Liechtenstein 1
MS - Montserrat 1
Totale 8.567
Città #
Dallas 1.137
Chandler 556
Singapore 470
Jacksonville 246
New York 183
Hong Kong 169
Princeton 152
Beijing 145
Ashburn 142
Nanjing 107
São Paulo 87
Dearborn 79
Los Angeles 58
Wilmington 56
Sassari 54
Ann Arbor 49
Shanghai 49
Rio de Janeiro 48
Nanchang 47
Boardman 35
Ho Chi Minh City 35
Munich 32
Tokyo 29
Woodbridge 29
Tianjin 24
Warsaw 24
Brasília 23
Shenyang 23
Belo Horizonte 22
Tashkent 21
Hebei 19
Nuremberg 19
Santa Clara 19
Baghdad 18
Helsinki 18
Toronto 18
Campinas 17
Curitiba 17
Hanoi 17
Brooklyn 16
Seoul 16
Brussels 15
Denver 15
San Francisco 15
Changsha 14
Chennai 14
Council Bluffs 14
Izmir 14
Ribeirão Preto 14
Buffalo 13
Guayaquil 13
Norwalk 13
Porto Alegre 13
San Mateo 13
Houston 12
Johannesburg 12
Poplar 12
São Bernardo do Campo 12
Amman 11
Andover 11
Augusta 11
Cagliari 11
Chicago 11
Columbus 11
Frankfurt am Main 11
Montreal 11
Mountain View 11
Ningbo 11
The Dalles 11
Guarulhos 10
Leawood 10
London 10
Osasco 10
Stockholm 10
Atlanta 9
Boston 9
Contagem 9
Jinan 9
Manaus 9
Nairobi 9
Orem 9
Ardabil 8
Fortaleza 8
Monmouth Junction 8
Salvador 8
São José dos Campos 8
Turku 8
Anápolis 7
Barbianello 7
Biên Hòa 7
Bragança Paulista 7
Guangzhou 7
Kunming 7
Lanzhou 7
Lima 7
Maceió 7
Manchester 7
Mexico City 7
Montevideo 7
Philadelphia 7
Totale 4.926
Nome #
Amniotic fluid stem cells morph into a cardiovascular lineage: analysis of a chemically induced cardiac and vascular commitment 216
Antiproliferative and proapoptotic effects of Inula viscosa extract on Burkitt lymphoma cell line. 200
Dysregulation of miRNAs in Soft Tissue Sarcomas 183
A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs) 178
Anti-senescence efficacy of radio-electric asymmetric conveyer technology 171
Activation and function of murine Cyclin T2A and Cyclin T2B during skeletal muscle differentiation. 171
Synthesis and Antineoplastic Evaluation of Novel Unsymmetrical 1,3,4-Oxadiazoles 152
Evaluation of EZH2 expression in hepatitis B patients 149
Sputum analysis: non-invasive early lung cancer detection 144
Design, synthesis, and biological screening of a series of 4′-fluoro-benzotriazole-acrylonitrile derivatives as microtubule-destabilising agents (MDAs) 140
CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation 139
Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements 134
Activation and function of cyclin T-Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy 132
A promyelocytic leukemia protein-thrombospondin-2 axis and the risk of relapse in neuroblastoma 132
Verteporfin exhibits anti-proliferative activity in embryonal and alveolar rhabdomyosarcoma cell lines 131
Cloning of murine CDK9/PITALRE and its tissue-specific expression in development 130
cDNA sequences of three sheep myeloid cathelicidins 129
Activation and function of cyclin T/Cdk9 (positive transcription elongation factor-b) in cardiac muscle cell hypertrophy 126
Activation of MyoD-dependent transcription by cdk9/cyclin T2 125
Biological Activity of a Novel, Cathelicidin-derived Antimicrobial Peptide from Sheep 124
Clarifying the molecular mechanism of tomentosin‑induced antiproliferative and proapoptotic effects in human multiple myeloma via gene expression profile and genetic interaction network analysis 124
Biological characterization of two novel chathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities 122
The role of enhancer of zeste homolog 2: From viral epigenetics to the carcinogenesis of hepatocellular carcinoma 119
Bromodomain Inhibitor JQ1 Provides Novel Insights and Perspectives in Rhabdomyosarcoma Treatment 119
Chemical synthesis structural features and biological activity of novel mammalian antibiotic peptides identified throw amplification of homologous cDNA sequences 119
Synthesis and cytotoxicity of novel hexahydrothienocyclohepta-pyridazinone derivatives 117
Frequent loss of pRb2/p130 in human ovarian carcinoma 116
Tet1 and Tdg suppress intestinal tumorigenesis by downregulating the inflammatory and immune responses in the Apc(Min)mouse model 113
A unique domain of pRb2/p130 acts as an inhibitor of cdk2 kinase activity 112
Physical interaction between pRb and cdk9/cyclinT2 complex 111
Modification of the base excision repair enzyme MBD4 by the small ubiquitin-like molecule SUMO1 110
Frequent loss of Rb2/p130 in human ovarian carcinoma 110
EZH2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A 109
12-O-tetradecanoylphorbol-13-acetate and EZH2 inhibition: A novel approach for promoting myogenic differentiation in embryonal rhabdomyosarcoma cells 109
Long noncoding RNA SYISL: the crucial interaction with EZH2 in skeletal muscle differentiation and disorders 107
Molecular cloning, expression and developmental characterization of the murine Retinoblastoma-related gene Rb2/p130 105
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 105
Novel 1,3,4-oxadiazole chalcogen analogues: Synthesis and cytotoxic activity 104
pRb2/p130 has an anti-apoptotic effect on apoptosis triggered by camptothecin and doxorubicin, and not by taxol 103
A new parameter of growth inhibition for cell proliferation assays 103
CTCF and BORIS Regulate Rb2/p130 Gene Transcription: A Novel Mechanism and a New Paradigm for Understanding the Biology of Lung Cancer 101
Cyclin E and Chromosome Instability (CIN) in colorectal cancer cell lines 100
Deacetylase recruitment by the C/H3 domain of the acetyltransferase p300 99
MyoD recruits the cdk9/cyclin T2 complex on myogenic-genes regulatory regions 98
Hyaluronan esters drive Smad gene expression and signaling enhancing cardiogenesis in mouse embryonic and human mesenchymal stem cells 98
SFK Inhibitors as New Strategy for RMS Treatment 97
Target identification of a novel unsymmetrical 1,3,4-oxadiazole derivative with antiproliferative properties 96
A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity and cell cycle arrest 95
Identification of 3-Aryl-1-benzotriazole-1-yl-acrylonitrile as a Microtubule-Targeting Agent (MTA) in Solid Tumors 94
“The Retinoblastoma Family Protein p130 as a Negative Regulator of Cell Growth and Tumor Progression” 93
TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype 92
Identification of murine cdk10: association with Ets2 transcription factor and effects on the cell cycle 92
From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb-E2F pathway 89
Cdk9-55: a new player in muscle regeneration 89
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment 88
Study of viral integration of HPV-16 in young patients with LSIL 86
Viral infections as a cause of cancer 85
Independent prognostic role of p16 expression in lung cancer 85
Phisical Interacton between cdk9 and B-Myb results in suppression of B-Myb gene autoregulation 85
Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1. 85
Role of Enhancer of Zeste Homolog 2 Polycomb Protein and Its Significance in Tumor Progression and Cell Differentiation 84
The BRG1 ATPase of chromatin remodelling complexes is involved in modulation of mesenchymal stem cell senescence through RB-P53 pathways 84
Roles of enhancer of zeste homolog 2: From skeletal muscle differentiation to rhadbomyosarcoma carcinogenesis. 83
Tomentosin a Sesquiterpene Lactone Induces Antiproliferative and Proapoptotic Effects in Human Burkitt Lymphoma by Deregulation of Anti- and Pro-Apoptotic Genes 83
PRC2: an epigenetic multiprotein complex with a key role in the development of rhabdomyosarcoma carcinogenesis 82
Tumor suppressor pRb2/p130 gene and its derived product Spa310 spacer domain as perspective candidates for cancer therapy 82
RNAseq Analysis of Novel 1,3,4-Oxadiazole Chalcogen Analogues Reveals Anti-Tubulin Properties on Cancer Cell Lines 80
The Retinoblastoma gene family pRb/p105, p107, pRb2/p130 and Simian Virus-40 Large-T antigen in human mesotheliomas 80
The ablation of EZH2 uncovers its crucial role in rhabdomyosarcoma formation 77
Preliminary study in early lung cancer detection using sputum sample 76
Nutraceuticals in Pregnancy: A Special Focus on Probiotics 75
Genomic Organization, Promoter Analysis, and Chromosomal Mapping of the Mouse Gene Encoding Cdk9 74
R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair 74
Roscovitine (Seliciclib, cyc202) prevents Cyclin A1 DNA damage induced up-regulation and reduces Double Strand Break (DSB) repair through NHEJ impairment. 71
The COOH-terminal Region of pRb2/p130 Binds to Histone Deacetilase 1 (HDAC1), Enhancing Transcriptional Repression of the E2F-dependent Cyclin A Promoter 68
Role of enhancer of zeste homolog 2 polycomb protein and its significance in tumor progression and cell differentiation 59
Cytometry and DNA Ploidy: Clinical Uses and Molecular Perspective in Gastric and Lung Cancer 58
Interaction Between the Cdk2/Cyclin A Complex and a Small Molecule Derived from the pRb2/p130 Spacer Domain: A Theoretical Model 56
null 47
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors 45
Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors 45
Silver nanoparticles derived by artemisia arborescens reveal anticancer and apoptosis-inducing effects 36
null 36
BET-inhibitor I-BET762 and PARP-inhibitor talazoparib synergy in small cell lung cancer cells 35
Essential oils by name and by nature: a review of their antioxidant and neuroprotective potential in Parkinson’s Disease 4
Totale 8.684
Categoria #
all - tutte 36.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.031


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021340 0 0 0 0 0 21 73 1 77 78 78 12
2021/2022382 46 2 2 8 2 7 13 35 29 34 38 166
2022/2023980 80 91 18 172 87 165 3 123 168 6 52 15
2023/2024387 46 14 14 5 44 155 9 22 0 6 49 23
2024/20252.598 24 23 136 52 65 95 225 475 854 443 118 88
2025/20262.745 258 956 484 598 404 45 0 0 0 0 0 0
Totale 8.684